Maryland House Passes New Bill On Generic Drug Pricing

Businessman with money handshaking with doctor isolated on white background

On March 20th, Maryland’s House of Delegates passed a bill which would look to prohibit pharma firms from overcharging for generic drugs. The bill would require the Maryland Medical Assistance Program to notify manufacturers of an essential generic drug and the attorney general of a specific increase in the price of an essential generic. Drug manufacturers of essential generics would also be required to submit a specified statement to the attorney general within 20 days of receiving a request to explain the price increase. The bill defines “price gouging” as generic drugs who see an increase of more than 50 percent in their wholesale acquisition costs over a single year.

Read the source article at

About the Author

Related Posts

Leave a Reply